THE AUGUST ISSUE
OF GOLD IS HERE!
Explore the new issue of GOLD! From investigating how pop culture’s pharma bias can be recalibrated, to exploring blockchain’s ever-growing presence in the pharma landscape, the latest issue of GOLD considers the most prominent trends, triumphs and tribulations across the industry.
Speaking with industry experts, this issue features an investigation into the future for MSLs, thoughts on the potential that social media holds for pharma and patients alike and a voyage to India to explore the country’s bustling pharma landscape. Topics include:
Building trust in genomics
Disparities in women’s health
A thought-provoking conversation with Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy, and Gastro-Intestinal Diseases, Sanofi
Featuring insight from a broad spectrum of experts, this issue explores key trends within the pharma industry including the ever-present issue of non-adherence, patient centricity from the patient perspective, the allure of public-private partnerships and much more.
Additional topics include:
Ensuring first-time launch success
Brazil’s strengthening pharma landscape
A discussion with Claus Zieler, President, Established Markets, Astellas
Featuring insight from a range of industry experts, this issue explores the key strategies and innovations for patient and customer engagement, the industry’s continued effort to restore normality following COVID-19, and crucial developments in drug development and market access. Topics include:
The power of gamification
The use of RWD and RWE
South Africa as a future pharma power
A captivating conversation with Davidek Herron, Global Head of Digital, Roche
YOU MIGHT ALSO LIKE..
Pharma’s next move in the online jungle
From search listening to engaging with patient influencers, there’s huge scope for pharma to further leverage the world of social media to drive better patient outcomes.
Bolstering data ownership with blockchain
As the data ownership and trade debate reaches pharma and healthcare, how could blockchain networks benefit patients and companies alike?
GOLD looks back at the pharmaceutical industry’s top news stories from the past few months.